Last updated on July 2020

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Brief description of study

The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.

Clinical Study Identifier: NCT03587805

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.